A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE

Chu, Fong Fong, Ph.D. Laboratory

Laboratory of Fong Fong Chu, Ph.D.
Glutathione Peroxidase in Mouse Inflammatory Bowel Disease and Radiation Protection
Inflammatory bowel disease (IBD) is consisted of Crohn’s disease, which always involves the ileum, and ulcerative colitis, which always involves the colon.  About one to two per thousand Americans are diagnosed with IBD each year, and most people diagnosed of Crohn’s disease are between 15-30 years old, when most people diagnosed of ulcerative colitis are in their 30s (www.ccfa.org).  Although IBD is not a life-threatening disease, it is painful, needs long-term management, and increases cancer risk in the ileum, the colon, and the rectum.
To better manage this disease, we need to better understand the cause and the progression of this disease. Many animal IBD models have been generated and analyzed for IBD etiology and treatment. Most studied animal IBD models are mouse models for ulcerative colitis.  There are only a couple of mouse models for Crohn’s disease, SAMP1/Yit mice and TNFΔARE mice, which overexpress tumor necrosis factor. We have recently generated a new mouse model for Crohn’s disease, by disruption of genes encoding for two Se-dependent glutathione peroxidases (GPXs), Gpx1 and Gpx2.  Gpx1/2-double knockout (DKO) mice have more severe ilealitis than colitis, and ten-times more of ileal tumors than colonic tumors.
There are three major factors in IBD etiology: genetic, environmental, and immunological; all have been confirmed in Gpx1/2-DKO mice.  Among the mouse inbred lines that we have studied, Gpx1/2-DKO mice on a pure 129/SvJ (129) genetic background have the worst pathology and symptoms; DKO mice on a mixed C57BL/6J (B6) and 129 (B6.129) genetic background still have intermediate symptom and pathology; when B6 DKO mice have very mild disease.  This disease is induced by luminal microflora, since germ-free Gpx1/2-DKO mice are disease-free.  Although these DKO mice are highly sensitive to certain microflora, the identity of the pathogens remains to be elusive.
Another important environmental factor affecting IBD outcome is the diet.  We have found DKO mice on defined diets have much better health than those on commercial rodent chows. Since dietary modulation provides the best health for these DKO mice than many conventional and experimental drugs for IBD, we plan to identify the component of diet that cause ileocolitis.
Increased in reactive oxygen species (ROS) has been observed in inflamed intestinal mucosa in IBD patients, however, it is believed to be caused by inflammation. ROS is also known to activate many pro-inflammatory cytokines presumably by activation of nuclear factor (NF) κB pathway, thus the ROS generated from inflammatory cells adds fuel to the fire and further damage the tissue. We are investigating that whether GPX protects intestinal epithelial cells from oxidative stress, and what are the downstream genes affected by GPX activity.
In addition to the role of GPX in prevention of ileocolitis that we have recently discovered, the antioxidant activity of GPX has long been suspected to protect cells against radiation damage. However, there is little evidence to support this claim.  Additionally, whether the radioprotective effect of Amifostine, a small molecule with superoxide dismutase activity, depends on GPX to reduce hydrogen peroxide is not known.  We plan to evaluate the role of GPX in protection of intestinal epithelial cells against γ-irradiation in near future.

Lab Members

Avo Artinyan, M.D.
Surgical Oncology Fellow
Ph 626-256-HOPE (4673)
Ext. 67100
Fax 626-930-5330
Steve Esworthy, Ph.D.
Assistant Research Scientist
Ph 626-256-HOPE (4673)
Ext. 62819
Fax 626-930-5330
Qiang Gao, M.D., Ph.D.
Research Fellow
Ph 626-256-HOPE (4673)
Ext. 65589
Fax 626-930-5330
Byung-Wook Kim, M.S.
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 62955
Fax 626-930-5330
Marucha Sanchez
Research Associate I
Ph 626-256-HOPE (4673)
Ext. 60412
Fax 626-930-5330
Our Scientists

Our research laboratories are led by the best and brightest minds in scientific research.

Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
Develop new therapies, diagnostics and preventions in the fight against cancer and other life-threatening diseases.
Support Our Research
By giving to City of Hope, you support breakthrough discoveries in laboratory research that translate into lifesaving treatments for patients with cancer and other serious diseases.
  • A common surgical device, often used for minimally invasive hysterectomies, may be riskier than previously thought because of its potential to spread several types of cancer, not just uterine cancer, a new study has found. One out of every 368 women treated with a power morcellator – a device that cuts the uter...
  • Skin cancer rates have been on the rise for years. On Tuesday, the U.S. surgeon general said: Enough. In issuing the first-ever Call to Action to Prevent Skin Cancer, acting Surgeon General Boris Lushniak described skin cancer as a “major public health problem” that requires action by all segments o...
  • Learn more about becoming a patient or getting a second opinion at City of Hope by visiting us online or by calling 800-826-HOPE (4673). City of Hope staff will explain what’s required for a consult at City of Hope and help you determine, before you come in, whether or not your insurance will pay for the ...
  • Counter-intuitive though it might seem, a prostate cancer diagnosis shouldn’t always lead to immediate prostate cancer treatment. Although prostate cancer is the second-leading cancer killer of men, behind lung cancer, and causes more than 29,000 deaths in the U.S. each year, in many cases, the tumors are...
  • Radiology is one of the cornerstones of any hospital. It is a key diagnostic branch of medicine essential for the initial diagnosis of many diseases and has an important role in monitoring a patient’s treatment and predicting outcome. Radiology is the specialty considered to be both the “eyes” and “ears” of med...
  • Donating blood and platelets saves lives. We all know this. Yet every summer, potential blood donors become distracted by vacations and schedule changes. As a result, blood donations fall dramatically across the nation, leaving hospitals frantically trying to bring in much-needed blood for their patients. Earli...
  • To be a great cancer hospital, you need a great oncology program. Just ask City of Hope – and Becker’s Hospital Review. The health care publishing industry stalwart, described as the “leading hospital magazine for hospital business news and analysis for hospital and health system executives,” recently selected ...
  • Diagnostic errors are far from uncommon. In fact, a recent study found that they affect about 12 million people, or 1 in 20 patients,  in the U.S. each year. With cancer, those errors in diagnosis can have a profound impact. A missed or delayed diagnosis can make the disease that much harder to treat, as the Ag...
  • Eleven years ago, lymphoma patient Christine Pechera began the long road toward a cancer-free life. She had been diagnosed with non-Hodgkin lymphoma and told by doctors elsewhere that her lifespan likely would be measured in months, not years. Refusing to give up, she came to City of Hope for a second opinion. ...
  • Brain surgery is not for the faint of heart. It takes courage, as well as curiosity and compassion. The truly great surgeons also have a desire to find new, and better ways, of healing the brain. Enter Behnam Badie, M.D., chief of neurosurgery at City of Hope. Now a pioneer in brain tumor treatment, Badie enter...
  • Elizabeth Budde, M.D., Ph.D., wants to encourage infighting. She aims to turn the immune system on itself — to the benefit of patients with acute myeloid leukemia, or AML. AML arises when abnormal white blood cells grow out of control, amassing in the bone marrow and interfering with normal blood cell developme...
  • Six, to date; more soon. Outpatient bone marrow transplants, that is. Finding new ways to deliver quality care with the greatest benefit is a priority for a patient-centered institution like City of Hope. For example, not every bone marrow transplant patient needs to check into the hospital for treatment. In fa...
  • The best measure of success in the fight against cancer is in lives saved and families intact, in extra days made special simply because they exist. Yuman Fong, M.D., chair of the Department of Surgery at City of Hope, understands what precedes that special awareness. When cancer strikes, one minute a person ma...
  • In cancer, expertise matters. So do survival rates, patient safety, patient services and many other factors. City of Hope understands this, as does U.S.News & World Report. The magazine’s 2014-2015 list of best hospitals for cancer once again includes City of Hope, ranking the institution 12 out of 900 elig...
  • At 29, Kommah McDowell was a successful young professional engaged to be married to her best friend. She worked in the financial services sector and kick-boxed to keep in shape and to relax. Then came the diagnosis of triple-negative inflammatory breast cancer, a rare and very aggressive form of breast cancer. ...